Reports >
Life Sciences
>
Veterinary Cro Market Report
Veterinary Cro Market Report
First published: 15 October 2024 | Last updated: 28 May 2026 | Report Code: veterinary-cro
Veterinary Cro Market — USD 2.5 billion in 2023, Growing to USD 5.16B by 2033 at 7.3% CAGR
This report provides an in-depth analysis of the Veterinary Contract Research Organization (CRO) market, offering insights into market size, growth potential, key players, and trends from 2023 to 2033.
Key Takeaways
- Global market value rises from $2.50 Billion in 2023 to $5.16 Billion in 2033, reflecting a 7.3% CAGR.
- North America is largest regional market; Latin America is regional market region based on implied CAGR across 2023 to 2033.
- Latin America is identified as the regional market region, increasing from $0.09 Billion to $0.2 Billion with an implied 8.31% CAGR.
- Europe, Asia Pacific, and Middle East & Africa all show steady expansion supported by rising animal health investment and service demand.
- Key service segments include preclinical, clinical and laboratory offerings, with pharmaceutical companies, biotechnology firms and academic institutions as core end users.
Veterinary Cro Market Report — Executive Summary
Regional analysis shows North America as largest market and Latin America as fastest-growing region by implied CAGR. This report examines the Veterinary CRO market structure, drivers, and participant landscape. Rising demand for efficient veterinary drug development, investments in animal health, and technological adoption underpin growth from $2.50 Billion in 2023 to $5.16 Billion in 2033 at a 7.3% CAGR. Regional dynamics vary: North America is the largest market, while Latin America shows the highest implied growth rate. Service segmentation covers preclinical, clinical and laboratory services, and primary clients include pharmaceutical companies, biotechnology firms and academic institutions. The competitive field features established providers such as Covance, Charles River Laboratories and Labcorp. Trends shaping the sector include advances in biotechnology, greater outsourcing of trial activities, and an increased focus on animal welfare. The analysis synthesizes primary interviews and secondary sources to offer actionable insight for stakeholders planning investments or partnerships.
Key Growth Drivers
- Greater outsourcing of veterinary R&D by pharmaceutical and biotechnology firms to improve development efficiency.
- Rising investment in animal health driven by higher pet ownership and demand for advanced therapeutics.
- Adoption of new laboratory and trial technologies that streamline study execution and data management.
- Expansion of clinical and preclinical capacities across regions to support faster program timelines.
- Collaboration between CROs and academic institutions to accelerate translational research and specialized services.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $2.50 Billion |
| CAGR (2023-2033) | 7.3% |
| 2033 Market Size | $5.16 Billion |
| Top Companies | Covance, Charles River Laboratories, Labcorp |
| Published Date | 15 October 2024 |
| Last Modified Date | 28 May 2026 |
Veterinary Cro Market Overview
Customize Veterinary Cro Market Report market research report
- ✔ Get in-depth analysis of Veterinary Cro market size, growth, and forecasts.
- ✔ Understand Veterinary Cro's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Veterinary Cro
What is the Market Size & CAGR of Veterinary Cro Market Report market in 2023?
Veterinary Cro Industry Analysis
Veterinary Cro Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Veterinary Cro Market Report Market Analysis Report by Region
Europe Veterinary Cro Market Report:
Europe grows from $0.73 Billion in 2023 to $1.5 Billion in 2033. Investments in animal health, regulatory focus on welfare, and collaborations between industry and academia contribute to expanded preclinical and clinical activities across the region.Asia Pacific Veterinary Cro Market Report:
Asia Pacific grows from $0.51 Billion in 2023 to $1.06 Billion in 2033. Market expansion is driven by rising veterinary healthcare investment, growing research capacity, and greater adoption of outsourced laboratory and clinical services.North America Veterinary Cro Market Report:
North America is largest regional market, rising from $0.85 Billion in 2023 to $1.76 Billion in 2033. Established clinical infrastructure, strong pharmaceutical and biotechnology spending, and concentrated service providers support continued demand for outsourced veterinary research.South America Veterinary Cro Market Report:
Latin America is fastest-growing region by implied CAGR, increasing from $0.09 Billion in 2023 to $0.2 Billion in 2033. 09 Billion in 2023 to $0.2 Billion in 2033 and is identified as the regional growth market with an implied 8.31% CAGR. Expanding research activities and growing animal health demand underpin regional service uptake.Middle East & Africa Veterinary Cro Market Report:
Middle East and Africa grows from $0.31 Billion in 2023 to $0.64 Billion in 2033. Increasing focus on animal health, developing research infrastructure, and demand for reliable laboratory services drive region-specific expansion.Tell us your focus area and get a customized research report.
Research Methodology
Veterinary Cro Market Analysis By Service Type
In 2023, the Veterinary CRO market by service type is led by preclinical services, valued at $1.64 billion, and expected to grow to $3.38 billion by 2033. Clinical services and laboratory services also exhibit strong growth potential, reflecting their critical roles in research and development processes.
Veterinary Cro Market Analysis By Animal Type
The market for companion animals dominates the Veterinary CRO landscape, constituting 65.47% of the share in 2023, with a market size of $1.64 billion, expanding to $3.38 billion by 2033. Food animals and exotic animals follow, highlighting the detailed segmentation and distinct requirements across the various animal health sectors.
Veterinary Cro Market Analysis By Study Phase
The discovery phase of veterinary drug development remains predominant, holding a 65.47% market share in 2023, valued at $1.64 billion and set to grow to $3.38 billion by 2033. This segment's significance reflects the innovative focus in veterinary medicine, with a strong pipeline of new products being explored.
Veterinary Cro Market Analysis By End User
Pharmaceutical companies represent a major end-user within the Veterinary CRO market, with a size of $1.64 billion in 2023. Their reliance on CROs for effective research and development contributes significantly to the market's growth projections, further driven by increasing competition in the pharmaceutical industry.
Veterinary Cro Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Veterinary Cro Industry
Covance:
Covance is a global leader in drug development services, providing comprehensive support to pharmaceutical and biotechnology companies including notable expertise in veterinary clinical trials.Charles River Laboratories:
Charles River Laboratories is a prominent contract research organization offering a range of services, including preclinical and clinical studies, well established in the veterinary CRO sector.Labcorp:
Labcorp excels in providing comprehensive laboratory services and has a strong portfolio in veterinary testing, supporting drug development processes for various veterinary applications.We're grateful to work with incredible clients.
FAQs
What is the market size of the Veterinary Cro Market Report in 2023?
The market size for 2023 is $2.50 Billion as stated in the report, representing the baseline value for the forecast period from 2023 to 2033.
How big is the Veterinary Cro Market Report expected to be in 2033?
The market is projected to reach $5.16 Billion in 2033 according to the forecast, reflecting growth across multiple regions and service segments.
What is CAGR of the Veterinary Cro Market Report for 2023 to 2033?
The compound annual growth rate for the period 2023 to 2033 is 7.3%, based on the reported increase from $2.50 Billion to $5.16 Billion.
Which region is the fastest Growing in the Veterinary Cro Market Report market?
Latin America is the fastest-growing region, projected to expand from $0.09 Billion in 2023 to $0.2 Billion in 2033, reflecting an implied 8.31% CAGR over the forecast period.
Which region is the fastest Growing for Veterinary CRO services?
Latin America is identified as the regional market region with an implied 8.31% CAGR, growing from $0.09 Billion in 2023 to $0.2 Billion in 2033.
Who are the primary clients for Veterinary CRO services?
Primary end users include pharmaceutical companies, biotechnology firms and academic institutions that outsource preclinical, clinical and laboratory tasks.
What service types are commonly offered by Veterinary CROs?
Common services include preclinical services, clinical services and laboratory services tailored to veterinary drug development and testing needs.
How is regional growth measured in the report?
Regional growth is presented using start and end market values for 2023 and 2033, alongside implied regional growth rates where explicitly provided.